
Important immunisation program information (RSV)

A new respiratory syncytial virus (RSV) maternal and infant program will commence ahead of winter 2025.
Under the comprehensive program:
- A single dose of RSV vaccine Abrysvo® will be available for people from 28 weeks of pregnancy under the National Immunisation Schedule (NIP).
Eligible infants up to 8 months old, including infants whose mothers did not have the option to be vaccinated against RSV; and children up to 2 years old with high-risk conditions, will have access to a state-funded Beyfortus™ (nirsevimab) monoclonal antibody immunisation.
New NIP Schedule
- An updated SA NIP Schedule is available with 2025 changes including the addition of the Abrysvo® vaccine.
Access training: An RSV immunisation education program has been developed by SA Health for South Australian immunisation providers. For information on this course and to register see Immunisation Provider training and education.
Maternal infant protection program | |
Timeframe |
|
Who can administer |
|
Eligible cohort |
|
Reporting |
|
Ordering from the Vaccine Distribution Centre |
|
More information | See the SA Health Pregnancy and Immunisation webpage and the Australian Government Immunisation for Pregnancy webpage. |
RSV infant protection program | |
Timeframe |
|
Who can administer |
|
Eligible cohort |
|
More information | More information on the mAb program will be available prior to the commencement of the program. |
For more information
- For further information about RSV, see the RSV fact sheet.
- For clinical guidance, refer to the Australian Immunisation Handbook’s RSV chapter.
- The SA Health Immunisation Section can be contacted on 1300 232 272.
30 January 2025